Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2021-11-15 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
211115 - Disposals of own shares_ENG.pdf
Transaction in Own Shares Classification · 100% confidence The document explicitly details the 'Disposals of own shares' conducted by the company (UCB) following the exercise of stock options under its Long Term Incentive Program. This activity involves the company transacting in its own stock, which directly corresponds to the definition of 'Transaction in Own Shares'. The filing is a press release announcing these specific transactions, not a comprehensive annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS). Therefore, the most specific category is POS (Transaction in Own Shares). The document length is relatively short (4023 chars) and it is a direct announcement of the transaction details.
2021-11-15 English
211115 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Aliénation d'actions propres" (Disposal of own shares) and details transactions where UCB SA disposed of its own shares following the exercise of stock options by employees as part of long-term variable remuneration. This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation plans. This aligns precisely with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement dated November 15, 2021, providing transaction details, which is characteristic of a POS filing rather than a general regulatory filing (RNS) or a report publication announcement (RPA), as it describes a specific corporate action.
2021-11-15 French
211115 - Vervreemding van eigen aandelen_NED.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the text details transactions where UCB shares were transferred to employees as part of long-term incentive plans (stock options). This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation/share schemes. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase/issuance. The document is a formal announcement dated November 15, 2021, and is short, indicating it is the announcement itself, not a comprehensive report.
2021-11-15 Dutch
211105 - Disposals of own shares_ENG.pdf
Transaction in Own Shares Classification · 98% confidence The document explicitly states 'Disposals of own shares' and details transactions where UCB disposed of its own shares OTC following stock option exercises under various Long Term Incentive Programs. This directly corresponds to the definition of a company reporting transactions involving its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a detailed report of these transactions, not just an announcement of a report.
2021-11-05 English
211105 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Aliénation d'actions propres" (Disposal of own shares) and details transactions where UCB SA alienated (sold/disposed of) its own shares following the exercise of options by personnel, as required by Belgian Royal Decree Article 8:6. This activity specifically relates to the company buying back or selling its own shares, often in the context of employee compensation plans. This directly matches the definition for 'Transaction in Own Shares' (POS). The document is a regulatory disclosure of these transactions, not a general announcement of a report (RPA) or a broad regulatory filing (RNS).
2021-11-05 French
211105 - Vervreemding van eigen aandelen_NED.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB shares were transferred to employees exercising stock options under various long-term incentive plans. This activity directly relates to the company managing its own share capital, specifically through the disposal or repurchase of treasury shares. The filing category 'Transaction in Own Shares' (POS) is the most appropriate fit for reporting share repurchases or disposals related to employee stock plans. The document is a formal announcement dated November 5, 2021, providing detailed transaction tables, which confirms it is a primary disclosure, not just an announcement of a report (RPA/RNS).
2021-11-05 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.